$DarioHealth (DRIO.US)$ DarioHealth Announces $25.6M Private Placement Positioning the Company to Execute on Strategy Aiming to Reach Operational Cash Flow Positive Run Rate by the End of 2025 Tuesday, 21st January at 8:30 am • Significant participation from existing shareholders and accredited healthcare investors, which the company believes underscores confidence in its strategy • Financing supports execution of long-term growth initiatives focused on high-margin, scalable recurring reven...
$DarioHealth (DRIO.US)$ DarioHealth Expands GLP-1 Weight-Loss Solution, Unlocking New Revenue Streams in Rapidly Growing Multi Billion Dollar Market Tuesday, 14th January at 12:09 pm Market News Alerts Updates that DarioHealth Corp. (NASDAQ: DRIO) is taking another bold step into the rapidly growing weight-loss market, now projected to exceed $100 billion annually by 2030. The company's latest move expands its GLP-1 offering with prescribing capabilities, positioning Dario to capture a ...
$DarioHealth (DRIO.US)$Reuters· 4 mins ago DarioHealth Expands GLP-1 Solution With Prescribing Capabilities Through Collaboration With Mediorbis, Targeting Employers and Direct-to-Consumer Markets
$DarioHealth (DRIO.US)$ DarioHealth Expands GLP-1 Solution with Prescribing Capabilities through Collaboration with MediOrbis, Targeting Employers and Direct-to-Consumer Markets Tuesday, 14th January at 8:30 am New collaboration enhances Dario's comprehensive GLP-1 offering with virtual physician management to meet growing demand from employers covering weight-loss medications, opening new revenue streams in direct-to-consumer and pharma channels NEW YORK, Jan. 14, 2025 /PRNewswire/ -- Januar...
$DarioHealth (DRIO.US)$ Dario Signs Four New Employer Contracts Across Full Product Suite DarioHealth (Nasdaq: DRIO) has secured four new self-insured employer contracts, expected to go live in Q1 2025. These contracts cover Dario's complete platform suite, with clients opting for multi-condition offerings rather than single-condition solutions. The company projects to achieve approximately 25 new client signings in 2024, representing a 35% growth in client base compared to 2023. These new ...
$DarioHealth (DRIO.US)$ Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals with Diabetes or Prediabetes DarioHealth Corp. (Nasdaq: DRIO) has published a new study in Frontiers in Endocrinology, demonstrating the effectiveness of its cardiometabolic solution for individuals with diabetes or prediabetes and depression. The research, involving 989 users over 12 months, reveals: Members with depression showed highe...
Report
No comment yet
Sign in to post a comment
Trending Stocks
Top Gaining Chinese Stocks Top Gaining Chinese Stocks
DarioHealth Stock Forum
DarioHealth Announces $25.6M Private Placement Positioning the Company to Execute on Strategy Aiming to Reach Operational Cash Flow Positive Run Rate by the End of 2025
Tuesday, 21st January at 8:30 am
• Significant participation from existing shareholders and accredited healthcare investors, which the company believes underscores confidence in its strategy
• Financing supports execution of long-term growth initiatives focused on high-margin, scalable recurring reven...
got any potential ? hurrmmm...
Target Value from analyst : 2usd
Fair value: 1.8 usd
DarioHealth Expands GLP-1 Weight-Loss Solution, Unlocking New Revenue Streams in Rapidly Growing Multi Billion Dollar Market
Tuesday, 14th January at 12:09 pm
Market News Alerts Updates that DarioHealth Corp. (NASDAQ: DRIO) is taking another bold step into the rapidly growing weight-loss market, now projected to exceed $100 billion annually by 2030. The company's latest move expands its GLP-1 offering with prescribing capabilities, positioning Dario to capture a ...
DarioHealth Expands GLP-1 Solution With Prescribing Capabilities Through Collaboration With Mediorbis, Targeting Employers and Direct-to-Consumer Markets
DarioHealth Expands GLP-1 Solution with Prescribing Capabilities through Collaboration with MediOrbis, Targeting Employers and Direct-to-Consumer Markets
Tuesday, 14th January at 8:30 am
New collaboration enhances Dario's comprehensive GLP-1 offering with virtual physician management to meet growing demand from employers covering weight-loss medications, opening new revenue streams in direct-to-consumer and pharma channels
NEW YORK, Jan. 14, 2025 /PRNewswire/ -- Januar...
Dario Signs Four New Employer Contracts Across Full Product Suite
DarioHealth (Nasdaq: DRIO) has secured four new self-insured employer contracts, expected to go live in Q1 2025. These contracts cover Dario's complete platform suite, with clients opting for multi-condition offerings rather than single-condition solutions. The company projects to achieve approximately 25 new client signings in 2024, representing a 35% growth in client base compared to 2023.
These new ...
Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals with Diabetes or Prediabetes
DarioHealth Corp. (Nasdaq: DRIO) has published a new study in Frontiers in Endocrinology, demonstrating the effectiveness of its cardiometabolic solution for individuals with diabetes or prediabetes and depression. The research, involving 989 users over 12 months, reveals:
Members with depression showed highe...
No comment yet